|
|
||||||||
Journal of Lipid Research, Vol 31, 2045-2055, Copyright © 1990 by Lipid Research, Inc.
ARTICLES |
KM Cianflone, Z Yasruel, MA Rodriguez, D Vas and AD Sniderman
McGill Unit, Royal Victoria Hospital, Montreal, Quebec, Canada.
Secretion of hepatic apoB lipoproteins removes excess triglyceride from the liver. However, the mechanism by which synthesis of apoB, which occurs on the rough endoplasmic reticulum, is coordinated with synthesis of triglyceride, which takes place in the smooth endoplasmic reticulum, is not known. To examine this question, we have manipulated intracellular synthesis of triglyceride and cholesteryl ester in HepG2 cells and determined the impact of these maneuvers on apoB secretion. Since cholesteryl ester is the only major lipid class synthesized in the rough endoplasmic reticulum, our hypothesis was that, in response to a fatty acid challenge, synthesis of cholesteryl ester rather than synthesis of triglyceride would be the immediate trigger to apoB secretion. Oleate complexed to bovine serum albumin caused intracellular triglyceride synthesis to increase 6-fold and cholesteryl ester synthesis to increase almost 3-fold, while apoB secretion into the medium increased by 2.5-fold (P less than 0.0125) at all time points between 4 and 24 h. Addition of acylation stimulating protein to the medium further stimulated both triglyceride and cholesteryl ester synthesis (58% and 108%, respectively) above oleate alone and this resulted in a 50% increase in apoB secretion (P less than 0.0025). By contrast, both progesterone and 2-bromooctanoate inhibited triglyceride and cholesteryl ester synthesis and these effects were associated with reduced apoB secretion. Lovastatin inhibited cholesteryl ester synthesis (45%, P less than 0.0025); however, at the doses used, triglyceride formation was unaffected. Under these circumstances, apoB secretion was reduced by 25% (P less than 0.05). Similarly, 58-035 (an inhibitor of acyl CoA:cholesterol acyltransferase) on the one hand reduced cholesteryl ester synthesis markedly (59%, P less than 0.005), but on the other increased triglyceride synthesis though not statistically significantly (65%, P NS), and again this resulted in decreased apoB secretion (25%, P less than 0.005). Control experiments established that changes in low density lipoprotein catabolism did not contribute importantly to the quantity of apoB in the medium. Taken together, the data indicate that, at least in HepG2 cells, there are parallel changes in cholesteryl ester synthesis and apoB secretion and suggest that it is cholesteryl ester synthesis, not triglyceride synthesis, that is the immediate regulator of apoB secretion when these cells are exposed to an increased influx of fatty acids. However, alternative or additional regulatory mechanisms, such as, for example, a role for acylation of apoB, are not excluded by these studies.
This article has been cited by other articles:
![]() |
H. Duez, B. Lamarche, R. Valero, M. Pavlic, S. Proctor, C. Xiao, L. Szeto, B. W. Patterson, and G. F. Lewis Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans Circulation, May 6, 2008; 117(18): 2369 - 2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W.K. Ng, G. F. Watts, P. H. R. Barrett, K.-A. Rye, and D. C. Chan Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels Diabetes Care, November 1, 2007; 30(11): 2945 - 2950. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ursini-Siegel, A. B. Rajput, H. Lu, V. Sanguin-Gendreau, D. Zuo, V. Papavasiliou, C. Lavoie, J. Turpin, K. Cianflone, D. G. Huntsman, et al. Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor Development Mol. Cell. Biol., September 15, 2007; 27(18): 6361 - 6371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulinski and J. E. Vance Lipid Homeostasis and Lipoprotein Secretion in Niemann-Pick C1-deficient Hepatocytes J. Biol. Chem., January 19, 2007; 282(3): 1627 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Basso, L. A. Freeman, C. Ko, C. Joyce, M. J. Amar, R. D. Shamburek, T. Tansey, F. Thomas, J. Wu, B. Paigen, et al. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited J. Lipid Res., January 1, 2007; 48(1): 114 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Ginsberg REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 383 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Liang, C. H. Kim, and N. D. Vaziri HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure Am J Physiol Renal Physiol, March 1, 2005; 288(3): F539 - F544. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Lewis, M. Naples, K. Uffelman, N. Leung, L. Szeto, and K. Adeli Intestinal Lipoprotein Production Is Stimulated by an Acute Elevation of Plasma Free Fatty Acids in the Fasting State: Studies in Insulin-Resistant and Insulin-Sensitized Syrian Golden Hamsters Endocrinology, November 1, 2004; 145(11): 5006 - 5012. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Vaziri and K. Liang ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1038 - F1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Liang, P. Oelkers, C. Guo, P.-C. Chu, J. L. Dixon, H. N. Ginsberg, and S. L. Sturley Overexpression of Human Diacylglycerol Acyltransferase 1, Acyl-CoA:Cholesterol Acyltransferase 1, or Acyl-CoA:Cholesterol Acyltransferase 2 Stimulates Secretion of Apolipoprotein B-containing Lipoproteins in McA-RH7777 Cells J. Biol. Chem., October 22, 2004; 279(43): 44938 - 44944. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.D. Vaziri and K.H. Liang Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibition Ameliorates Proteinuria, Hyperlipidemia, Lecithin-Cholesterol Acyltransferase, SRB-1, and Low-Denisty Lipoprotein Receptor Deficiencies in Nephrotic Syndrome Circulation, July 27, 2004; 110(4): 419 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Lapierre, D. L. Currie, Z. Yao, J. Wang, and R. S. McLeod Amino acid sequences within the {beta}1 domain of human apolipoprotein B can mediate rapid intracellular degradation J. Lipid Res., February 1, 2004; 45(2): 366 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashi, H. Itabe, H. Fukase, M. Mori, Y. Fujimoto, and T. Takano Transmembrane Lipid Transfer Is Crucial for Providing Neutral Lipids during Very Low Density Lipoprotein Assembly in Endoplasmic Reticulum J. Biol. Chem., June 6, 2003; 278(24): 21450 - 21458. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pal, N. Ho, C. Santos, P. Dubois, J. Mamo, K. Croft, and E. Allister Red Wine Polyphenolics Increase LDL Receptor Expression and Activity and Suppress the Secretion of ApoB100 from Human HepG2 Cells J. Nutr., March 1, 2003; 133(3): 700 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Liang and N. D. Vaziri Upregulation of acyl-CoA:cholesterol acyltransferase in chronic renal failure Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E676 - E681. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishimaki-Mogami, Z. Yao, and K. Fujimori Inhibition of phosphatidylcholine synthesis via the phosphatidylethanolamine methylation pathway impairs incorporation of bulk lipids into VLDL in cultured rat hepatocytes J. Lipid Res., July 1, 2002; 43(7): 1035 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Merzouk, S. Madani, A. Boualga, J. Prost, M. Bouchenak, and J. Belleville Age-related changes in cholesterol metabolism in macrosomic offspring of rats with streptozotocin-induced diabetes J. Lipid Res., July 1, 2001; 42(7): 1152 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. REDMAN and H. XIA Fibrinogen Biosynthesis: Assembly, Intracellular Degradation, and Association with Lipid Synthesis and Secretion Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 480 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Wilcox, N. M. Borradaile, L. E. de Dreu, and M. W. Huff Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP J. Lipid Res., May 1, 2001; 42(5): 725 - 734. [Abstract] [Full Text] |
||||
![]() |
C. Maugeais, K. Ouguerram, R. Frénais, P. Maugère, B. Charbonnel, T. Magot, and M. Krempf Effect of Low-Density Lipoprotein Apheresis on Kinetics of Apolipoprotein B in Heterozygous Familial Hypercholesterolemia J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1679 - 1686. [Abstract] [Full Text] |
||||
![]() |
Z. Li, Y. Kako, L. Pang, M. W. Freeman, J. M. Glick, X. Wang, and I. J. Goldberg Effects of overexpression of the amino-terminal fragment of apolipoprotein B on apolipoprotein B and lipoprotein production J. Lipid Res., December 1, 2000; 41(12): 1912 - 1920. [Abstract] [Full Text] |
||||
![]() |
C. W. Joyce, G. S. Shelness, M. A. Davis, R. G. Lee, K. Skinner, R. A. Anderson, and L. L. Rudel ACAT1 and ACAT2 Membrane Topology Segregates a Serine Residue Essential for Activity to Opposite Sides of the Endoplasmic Reticulum Membrane Mol. Biol. Cell, November 1, 2000; 11(11): 3675 - 3687. [Abstract] [Full Text] |
||||
![]() |
N. Elias, B. W. Patterson, and G. Schonfeld In Vivo Metabolism of ApoB, ApoA-I, and VLDL Triglycerides in a Form of Hypobetalipoproteinemia Not Linked to the ApoB Gene Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1309 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pihlajamaki, L. Karjalainen, P. Karhapaa, I. Vauhkonen, and M. Laakso Impaired Free Fatty Acid Suppression During Hyperinsulinemia Is a Characteristic Finding in Familial Combined Hyperlipidemia, but Insulin Resistance Is Observed Only in Hypertriglyceridemic Patients Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 164 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Murray, A. D. Sniderman, and K. Cianflone Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E474 - E480. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Riches, G. F. Watts, J. Hua, G. R. Stewart, R. P. Naoumova, and P. H. R. Barrett Reduction in Visceral Adipose Tissue Is Associated with Improvement in Apolipoprotein B-100 Metabolism in Obese Men J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2854 - 2861. [Abstract] [Full Text] |
||||
![]() |
J. R. Burnett, L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs J. Lipid Res., July 1, 1999; 40(7): 1317 - 1328. [Abstract] [Full Text] |
||||
![]() |
L. J. Wilcox, P. H. R. Barrett, and M. W. Huff Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin J. Lipid Res., June 1, 1999; 40(6): 1078 - 1089. [Abstract] [Full Text] |
||||
![]() |
J. Saleh, N. Christou, and K. Cianflone Regional specificity of ASP binding in human adipose tissue Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E815 - E821. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Wilcox, P. H. R. Barrett, R. S. Newton, and M. W. Huff ApoB100 Secretion From HepG2 Cells is Decreased by the ACAT Inhibitor CI-1011 : An Effect Associated With Enhanced Intracellular Degradation of ApoB Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 939 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Kendrick and J. A. Higgins Dietary fish oils inhibit early events in the assembly of very low density lipoproteins and target apoB for degradation within the rough endoplasmic reticulum of hamster hepatocytes J. Lipid Res., March 1, 1999; 40(3): 504 - 514. [Abstract] [Full Text] |
||||
![]() |
A. Theriault, Q. Wang, A. Gapor, and K. Adeli Effects of {gamma}-Tocotrienol on ApoB Synthesis, Degradation, and Secretion in HepG2 Cells Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 704 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, K. Cianflone, and A. D. Sniderman Role of Cholesterol Ester Mass in Regulation of Secretion of ApoB100 Lipoprotein Particles by Hamster Hepatocytes and Effects of Statins on That Relationship Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 743 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Shelness, M. F. Ingram, X. F. Huang, and J. A. DeLozier Apolipoprotein B in the Rough Endoplasmic Reticulum: Translation, Translocation and the Initiation of Lipoprotein Assembly J. Nutr., February 1, 1999; 129(2): 456 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, H. N. Ginsberg, and X. Wu Glucose does not stimulate apoprotein B secretion from HepG2 cells because of insufficient stimulation of triglyceride synthesis J. Lipid Res., November 1, 1998; 39(11): 2277 - 2285. [Abstract] [Full Text] |
||||
![]() |
R. A. Anderson, C. Joyce, M. Davis, J. W. Reagan, M. Clark, G. S. Shelness, and L. L. Rudel Identification of a Form of Acyl-CoA:Cholesterol Acyltransferase Specific to Liver and Intestine in Nonhuman Primates J. Biol. Chem., October 9, 1998; 273(41): 26747 - 26754. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Karjalainen, J. Pihlajamaki, P. Karhapaa, and M. Laakso Impaired Insulin-Stimulated Glucose Oxidation and Free Fatty Acid Suppression in Patients with Familial Combined Hyperlipidemia : A Precursor Defect for Dyslipidemia? Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1548 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Riches, G. F. Watts, F. M. van Bockxmeer, J. Hua, S. Song, S. E. Humphries, and P. J. Talmud Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men J. Lipid Res., September 1, 1998; 39(9): 1752 - 1758. [Abstract] [Full Text] |
||||
![]() |
A. Mohammadi, J. Macri, R. Newton, T. Romain, D. Dulay, and K. Adeli Effects of Atorvastatin on the Intracellular Stability and Secretion of Apolipoprotein B in HepG2 Cells Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 783 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Sniderman, K. Cianflone, P. Arner, L. K. M. Summers, and K. N. Frayn The Adipocyte, Fatty Acid Trapping, and Atherogenesis Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 147 - 151. [Full Text] [PDF] |
||||
![]() |
J. R. Burnett, L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff Inhibition of HMG-CoA Reductase by Atorvastatin Decreases Both VLDL and LDL Apolipoprotein B Production in Miniature Pigs Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2589 - 2600. [Abstract] [Full Text] |
||||
![]() |
M. Cuchel, E. J. Schaefer, J. S. Millar, P. J.H. Jones, G. G. Dolnikowski, C. Vergani, and A. H. Lichtenstein Lovastatin Decreases De Novo Cholesterol Synthesis and LDL Apo B-100 Production Rates in Combined-Hyperlipidemic Males Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1910 - 1917. [Abstract] [Full Text] |
||||
![]() |
S.-L. Wang, E. Z. Du, T. D. Martin, and R. A. Davis Coordinate Regulation of Lipogenesis, the Assembly and Secretion of Apolipoprotein B-containing Lipoproteins by Sterol Response Element Binding Protein 1 J. Biol. Chem., August 1, 1997; 272(31): 19351 - 19358. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pihlajamaki, J. Rissanen, S. Heikkinen, L. Karjalainen, and M. Laakso Codon 54 Polymorphism of the Human Intestinal Fatty Acid Binding Protein 2 Gene Is Associated With Dyslipidemias But Not With Insulin Resistance in Patients With Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1039 - 1044. [Abstract] [Full Text] |
||||
![]() |
F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, G. G. Dolnikowski, J. M. Ordovas, and E. J. Schaefer Decreased Production and Increased Catabolism of Apolipoprotein B-100 in Apolipoprotein B-67/B-100 Heterozygotes Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 881 - 888. [Abstract] [Full Text] |
||||
![]() |
A. E. Rusinol, H. Jamil, and J. E. Vance In Vitro Reconstitution of Assembly of Apolipoprotein B48-containing Lipoproteins J. Biol. Chem., March 21, 1997; 272(12): 8019 - 8025. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.J. Martins, B.-C. Mortimer, and T.G. Redgrave Effect of the ACAT Inhibitor CL 277,082 on Apolipoprotein B48 Transport in Mesenteric Lymph and on Plasma Clearance of Chylomicrons and Remnants Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 211 - 216. [Abstract] [Full Text] |
||||
![]() |
F. Benoist and T. Grand-Perret ApoB-100 Secretion by HepG2 Cells Is Regulated by the Rate of Triglyceride Biosynthesis but Not by Intracellular Lipid Pools Arterioscler. Thromb. Vasc. Biol., October 1, 1996; 16(10): 1229 - 1235. [Abstract] [Full Text] |
||||
![]() |
P. J. Uelmen, K. Oka, M. Sullivan, C. C. Y. Chang, T. Y. Chang, and L. Chan Tissue-specific Expression and Cholesterol Regulation of Acylcoenzyme A:Cholesterol Acyltransferase (ACAT) in Mice J. Biol. Chem., November 3, 1995; 270(44): 26192 - 26201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Selby and Z. Yao Level of Apolipoprotein B mRNA Has an Important Effect on the Synthesis and Secretion of Apolipoprotein B–Containing Lipoproteins : Studies on Transfected Hepatoma Cell Lines Expressing Recombinant Human Apolipoprotein B Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1900 - 1910. [Abstract] [Full Text] |
||||
![]() |
G. J. Warner, G. Stoudt, M. Bamberger, W. J. Johnson, and G. H. Rothblat Cell Toxicity Induced by Inhibition of Acyl Coenzyme A:Cholesterol Acyltransferase and Accumulation of Unesterified Cholesterol J. Biol. Chem., March 17, 1995; 270(11): 5772 - 5778. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Spady, M. N. Willard, and R. S. Meidell Role of Acyl-Coenzyme A:Cholesterol Acyltransferase-1 in the Control of Hepatic Very Low Density Lipoprotein Secretion and Low Density Lipoprotein Receptor Expression in the Mouse and Hamster J. Biol. Chem., August 25, 2000; 275(35): 27005 - 27012. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |